(S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity.

[1]  S. Pyne,et al.  FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells , 2010, Cellular signalling.

[2]  R. Agarwal,et al.  Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells. , 2010, Cellular signalling.

[3]  N. Mochizuki,et al.  Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P3 Receptor: Investigation Based on a New S1P3 Receptor Antagonist , 2010, Molecular Pharmacology.

[4]  A. L. Howard,et al.  Characterization of non-lipid autotaxin inhibitors. , 2010, Bioorganic & medicinal chemistry.

[5]  V. Brinkmann.  FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system , 2009, British journal of pharmacology.

[6]  S. Dudek,et al.  Synthetic Analogs of FTY720 [2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] Differentially Regulate Pulmonary Vascular Permeability in Vivo and in Vitro , 2009, Journal of Pharmacology and Experimental Therapeutics.

[7]  R. Bittman,et al.  Chiral vinylphosphonate and phosphonate analogues of the immunosuppressive agent FTY720. , 2009, The Journal of organic chemistry.

[8]  R. Bittman,et al.  Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-de pend ent Manner* , 2009, The Journal of Biological Chemistry.

[9]  J. Garcia,et al.  FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells* , 2009, Journal of Biological Chemistry.

[10]  V. Brinkmann,et al.  Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. , 2008, Cancer letters.

[11]  A. Shiraishi,et al.  Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. , 2008, Biochemical and biophysical research communications.

[12]  S. Payne,et al.  The Immunomodulator FTY720 Has a Direct Cytoprotective Effect in Oligodendrocyte Progenitors , 2007, Journal of Pharmacology and Experimental Therapeutics.

[13]  J. Karliner,et al.  Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart , 2007, Journal of biochemical and molecular toxicology.

[14]  M. Caligiuri,et al.  FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. , 2007, The Journal of clinical investigation.

[15]  R. Proia,et al.  Essential Requirement for Sphingosine Kinase 2 in a Sphingolipid Apoptosis Pathway Activated by FTY720 Analogues* , 2007, Journal of Biological Chemistry.

[16]  J. Cyster,et al.  Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.

[17]  T. Hla,et al.  Immunosuppressive and Anti-angiogenic Sphingosine 1-Phosphate Receptor-1 Agonists Induce Ubiquitinylation and Proteasomal Degradation of the Receptor* , 2007, Journal of Biological Chemistry.

[18]  S. Payne,et al.  The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. , 2007, Blood.

[19]  S. Spiegel,et al.  Novel role of sphingosine kinase 1 as a mediator of neurotrophin‐3 action in oligodendrocyte progenitors , 2005, Journal of neurochemistry.

[20]  B. Oskouian,et al.  The Immune Modulator FTY720 Inhibits Sphingosine-1-phosphate Lyase Activity* , 2005, Journal of Biological Chemistry.

[21]  Ying Xu,et al.  Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients , 2005, Science.

[22]  K. Kikuchi,et al.  Inhibition of Autotaxin by Lysophosphatidic Acid and Sphingosine 1-Phosphate* , 2005, Journal of Biological Chemistry.

[23]  Michael D. Davis,et al.  Sphingosine 1-Phosphate Analogs as Receptor Antagonists* , 2005, Journal of Biological Chemistry.

[24]  J. Brown,et al.  G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival , 2004, Journal of cellular biochemistry.

[25]  G. Mills,et al.  Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. , 2003, Cancer research.

[26]  M. Ikekita,et al.  A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells , 2003, British journal of pharmacology.

[27]  K. Fukuzawa,et al.  Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.

[28]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[29]  Michael D. Davis,et al.  The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.

[30]  H. Rosen,et al.  Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.

[31]  T. Hanano,et al.  Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. , 2000, Journal of medicinal chemistry.

[32]  T. Bleu,et al.  Transduction of intracellular calcium signals through G protein-mediated activation of phospholipase C by recombinant sphingosine 1-phosphate receptors. , 1999, Molecular pharmacology.

[33]  C. H. Liu,et al.  Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. , 1999, Molecular biology of the cell.

[34]  S. Spiegel,et al.  Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.

[35]  M. Lew,et al.  Analysis of competitive agonist-antagonist interactions by nonlinear regression. , 1995, Trends in pharmacological sciences.

[36]  E. Billy,et al.  Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. , 2006, Cancer research.